Iodine-125

vasoactive intestinal peptide ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 8758916 Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. 1996 Aug 1 3
2 7694477 VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells. 1993 Oct 3
3 8383439 Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. 1993 Feb 2
4 8387187 Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells. 1993 Mar-Apr 1
5 1978437 Decreased binding of HIV-1 and vasoactive intestinal peptide following plasma membrane fluidization of CD4+ cells by phenytoin. 1990 Dec 2
6 2474824 Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. 1989 Aug 2
7 2825352 Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line. 1987 Dec 11 3
8 3007497 [mono[125I]iodo-Tyr10,MetO17]-vasoactive intestinal polypeptide. Preparation, characterization, and use for radioimmunoassay and receptor binding. 1986 Apr 25 1
9 3012658 Comparison of mammalian VIP bioactivities in dispersed acini from guinea pig pancreas. 1986 Mar 2
10 2998337 Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29. 1985 Oct 1 1
11 4043073 Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29). 1985 Oct 1 1